Amat di San Filippo C, Taylor MR, Mestroni L, et al.Cardiomyopathy and carnitine deficiency[J].Mol Genet Metab,2008, 94(6): 162-166.
[2]
Li FY, E-Hattab AW, Bawle EV, et al.Molecular spectrum of SLC22A5(OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine defciency[J].Hum Mutat, 2010,31(8): 1632-1651.
[3]
Lee NC, Tang NL, Chien YH, et al.Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening[J].Mol Genet Metab, 2010, 100(1): 46-50.
Lindner M, Gramer G, Haege G, et al.Efficacy and outcome of expanded newborn screening for metabolic diseases-report of 10 years from South-West Germany[J].Orphanet J Rare Dis, 2011,6: 44.
Laforet P, Vianey-Saban C.Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges[J].Neuromuscul Disord, 20l0, 20(11): 693-700.
[8]
Komlosi K, Magyari L, Talian GC, et al.Plasma carnitine ester profile in homozygous and heterozygous OCTN2 deficiency[J].J Inherit Metab Dis, 2009, 32(Suppl 1): S15-S19.
[9]
Jalil M A, Horiuchi M, Wakamatsu M, et al.Attenuation of cardiac hypertrophy in carnitine-deficient juveniIe visceral steatosis(JVS)mice achieved by lowering dietary lipid[J].J Biochem, 2006, l39(2): 263-270.
